The Relative Strength (RS) Rating for Aflac moved into a new percentile Friday, as it got a lift from 69 to 75.
How To Invest In Stocks In Both Bull And Bear Markets
IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks compares to other publicly traded companies.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 as they launch their largest price moves. See if Aflac can continue to rebound and clear that threshold.
Aflac is working on a consolidation with a 115.50 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
The company showed 1% earnings growth in the latest quarterly report. Sales gains came in at -37%.
The company holds the No. 4 rank among its peers in the Insurance-Accident & Healthcare industry group. Unum Group is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
